ATE323094T1 - Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen - Google Patents

Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen

Info

Publication number
ATE323094T1
ATE323094T1 AT03795686T AT03795686T ATE323094T1 AT E323094 T1 ATE323094 T1 AT E323094T1 AT 03795686 T AT03795686 T AT 03795686T AT 03795686 T AT03795686 T AT 03795686T AT E323094 T1 ATE323094 T1 AT E323094T1
Authority
AT
Austria
Prior art keywords
disorder
benzodioxans
heterocycles
condensed
anxiety
Prior art date
Application number
AT03795686T
Other languages
English (en)
Inventor
Gary Paul Stack
Deborah Ann Evrard
Uresh Shantilal Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE323094T1 publication Critical patent/ATE323094T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT03795686T 2002-09-12 2003-09-11 Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen ATE323094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41007202P 2002-09-12 2002-09-12
US10/659,174 US6911445B2 (en) 2002-09-12 2003-09-10 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans

Publications (1)

Publication Number Publication Date
ATE323094T1 true ATE323094T1 (de) 2006-04-15

Family

ID=31997897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03795686T ATE323094T1 (de) 2002-09-12 2003-09-11 Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen

Country Status (20)

Country Link
US (1) US6911445B2 (de)
EP (1) EP1546151B1 (de)
JP (1) JP2006503040A (de)
KR (1) KR20050042187A (de)
CN (1) CN1309722C (de)
AT (1) ATE323094T1 (de)
AU (1) AU2003266029A1 (de)
BR (1) BR0314430A (de)
CA (1) CA2498131A1 (de)
DE (1) DE60304590T2 (de)
DK (1) DK1546151T3 (de)
EC (1) ECSP055659A (de)
ES (1) ES2259776T3 (de)
MX (1) MXPA05002838A (de)
NO (1) NO20051770L (de)
NZ (1) NZ539253A (de)
PT (1) PT1546151E (de)
RU (1) RU2005107591A (de)
SI (1) SI1546151T1 (de)
WO (1) WO2004024732A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
JP2008530229A (ja) * 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
US20080139546A1 (en) * 2006-09-29 2008-06-12 Wyeth Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
CL2008001563A1 (es) * 2007-05-30 2008-10-10 Wyeth6 3 Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
AR004229A1 (es) 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9627005D0 (en) 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) * 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
US6162803A (en) * 1998-04-08 2000-12-19 American Home Products Corp. Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression
JP2002510682A (ja) * 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のインドール−3−イル−シクロヘキシルアミン誘導体(5−ht1受容体拮抗薬)
SI1392697T1 (en) 2001-03-14 2005-02-28 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f)quinoline
ES2229138T3 (es) 2001-04-26 2005-04-16 Wyeth Derivados antidepresivos azaheterociclilmetilicos de (1,4)- benzodiaxanos condensados con oxaheterociclos.

Also Published As

Publication number Publication date
CA2498131A1 (en) 2004-03-25
CN1309722C (zh) 2007-04-11
DK1546151T3 (da) 2006-07-31
DE60304590T2 (de) 2007-05-10
AU2003266029A1 (en) 2004-04-30
NO20051770L (no) 2005-06-07
EP1546151A1 (de) 2005-06-29
EP1546151B1 (de) 2006-04-12
PT1546151E (pt) 2006-07-31
US6911445B2 (en) 2005-06-28
SI1546151T1 (sl) 2006-08-31
WO2004024732A1 (en) 2004-03-25
US20040171667A1 (en) 2004-09-02
RU2005107591A (ru) 2006-01-20
JP2006503040A (ja) 2006-01-26
ES2259776T3 (es) 2006-10-16
HK1073849A1 (en) 2005-10-21
NZ539253A (en) 2006-09-29
ECSP055659A (es) 2005-07-06
CN1681821A (zh) 2005-10-12
MXPA05002838A (es) 2005-08-16
BR0314430A (pt) 2005-09-27
DE60304590D1 (de) 2006-05-24
KR20050042187A (ko) 2005-05-04

Similar Documents

Publication Publication Date Title
NO20051769L (no) Antidepressivt virkende azaheterocykylmetylderivater av heterocykluskondenserte benzodioksaner
PL368442A1 (pl) Pochodne fenylopiperazyny jako inhibitory wychwytu zwrotnego serotoniny
BR0314277A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
NO20083066L (no) Antistoffmolekyler med spesifisitet for human-IL-6
DE502004011239D1 (de) Verfahren zur dehydratisierung substituierter 4-dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-katalyse
ATE281459T1 (de) Azaheterocyclylmethyl derivative des 2,3-dihydro- 1,4-dioxino(2,3-f)quinolins als antidepressiva
ATE323094T1 (de) Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen
DE60315843D1 (de) Antidepressive indolalkylderivate von heterozyklisch-kondensierten benzodioxanmethylaminen
BR0209343A (pt) Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los
WO2002088136A3 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
BRPI0607224A2 (pt) processo para preparação de ciclohexanona e ciclohexanol
BR0209342A (pt) Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los
BR0314431A (pt) Derivados de piperidina antidepressiva dos benzodioxanos fundidos por heterocilo
EA200801081A1 (ru) Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
ATE402136T1 (de) Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte
NO20061167L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og en glysintransporter type 1-inhibitor for behandling av depresjon
BRPI0508059A (pt) método para preparação de pirrolidina oximas
BR0314280A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
EA201001799A1 (ru) Новые способы получения пиперазинильных и диазепанильных производных бензамида
EA200501577A1 (ru) Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина
ATE417055T1 (de) Steroid modifizierte solatriosen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1546151

Country of ref document: EP

REN Ceased due to non-payment of the annual fee